Physician profile
Richard Kahn
NPI 1114957503
$645.44
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $29.00 · 2021: $13.40 · 2022: $97.24 · 2023: $361 · 2024: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $505.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $205.78 | 2020-2024 | Trelegy Ellipta, Nucala |
| Genzyme Corporation | $100.13 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $66.44 | 2023-2024 | Tezspire, Breztri, Fasenra |
| Novartis Pharmaceuticals Corporation | $66.42 | 2023-2024 | |
| Mylan Specialty L.P. | $61.56 | 2022-2023 | Yupelri |
| Amgen INC. | $34.12 | 2024 | Tezspire |
| Jazz Pharmaceuticals INC. | $28.37 | 2024 | |
| Philips North America LLC | $26.99 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.54 | 2023 | Ofev |
| Harmony Biosciences LLC | $17.26 | 2024 | |
| Electromed, INC. | $14.83 | 2023 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Kahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.